David Bunn, MD, MPH

Harvard University

David Bunn is a fourth-year internal medicine resident and John McArthur Medicine Leadership fellow at Brigham and Women’s Hospital, and an MBA candidate at Harvard Business School. He earned his MD from Harvard Medical School and an MPH in Health Policy from the Harvard T.H. Chan School of Public Health, after completing his Bachelor of Science in Biology at the University at Albany. His research sits at the intersection of cardiology, health policy, and digital innovation. His work has focused on telehealth, Medicare Advantage, and, more recently, AI-enabled care delivery through Mass General Brigham’s Accelerator for Clinical Transformation to enhance cardiovascular care. Beyond his research, David co-founded Aidra Health, a venture improving medical equipment access in Nigeria. He is passionate about care delivery innovation, equity, and the thoughtful integration of technology into clinical practice to enhance patient care.

‍

What is a healthcare advancement you hope to see in your lifetime?

The healthcare advancement I most hope to see in my lifetime is the evolution of AI into a tool that not only enables precision medicine, tailoring therapies to each patient's unique clinical and biological context but also reinforces the humanistic aspects of health care. By easing administrative tasks and supporting clinical workflows, AI can help create a more patient-centered system‚ one that frees providers to focus on the relationships at the heart of medicine while empowering patients to better understand and engage in their health care.

‍

What excites you most about working with ARTIS?

What excites me the most about ARTIS is the opportunity to work alongside passionate individuals who share a commitment to transforming healthcare. I am inspired by ARTIS's mission to make meaningful, impact-driven investments in companies that address real patient needs and challenges in healthcare.

‍